International Biotechnology (LON:IBT – Get Free Report) shares crossed above its 200-day moving average during trading on Wednesday . The stock has a 200-day moving average of GBX 666.09 and traded as high as GBX 841.99. International Biotechnology shares last traded at GBX 826, with a volume of 106,750 shares.
International Biotechnology Price Performance
The stock has a 50-day simple moving average of GBX 765.55 and a 200 day simple moving average of GBX 666.09. The company has a market capitalization of £268.07 million, a PE ratio of 17.13 and a beta of 0.21.
International Biotechnology (LON:IBT – Get Free Report) last posted its earnings results on Thursday, November 6th. The company reported GBX (11.42) EPS for the quarter. International Biotechnology had a return on equity of 13.67% and a net margin of 90.66%. As a group, research analysts predict that International Biotechnology will post 0.9435943 EPS for the current fiscal year.
International Biotechnology Company Profile
The Company’s investment objective is to achieve long-term capital growth by investing in biotechnology and other life sciences companies.
The Company will seek to achieve its objective by investing in a diversified portfolio of companies which may be quoted or unquoted and whose shares are considered to have good growth prospects, with experienced management and strong potential upside through the development and/or commercialisation of a product, device or enabling technology.
Further Reading
- Five stocks we like better than International Biotechnology
- How to Invest in Small Cap Stocks
- 3 Cash-Rich Stocks With High Growth Potential Right Now
- Dividend Screener: How to Evaluate Dividend Stocks Before Buying
- Why Vertical Aerospace Stock Could Double After This Flight Test
- The 3 Best Retail Stocks to Shop for in August
- Amazon: Breakout Confirmed—Here’s Where It Could Go Next
Receive News & Ratings for International Biotechnology Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for International Biotechnology and related companies with MarketBeat.com's FREE daily email newsletter.
